Report: Patent Activity At A High But Decline In Scientific Research Could Show Innovation Slowing 04/06/2015 by Eimear Murphy for Intellectual Property Watch 1 Comment Patent activity is currently at an all-time high, with statistics showing large growth across industry sectors in the volume of patents being filed. However, the production of scientific literature is declining, according to a new report from Thomson Reuters.
European Parliament Trade Committee Tries To Defuse TTIP Controversy But Outcome Remains Uncertain 29/05/2015 by Dugie Standeford for Intellectual Property Watch 1 Comment European Commission negotiators should back away from a controversial provision in the Transatlantic Trade and Investment Partnership (TTIP) deal that would allow companies to sue governments in arbitration courts over claimed unequal treatment, the European Parliament International Trade Committee (INTA) said on 28 May. MEPs called instead for publicly appointed, independent judges, public hearings and an appellate mechanism that respects the jurisdiction of EU and national courts, the committee said.
140+ NGOs Urge WTO Members To Grant Extension Of LDC Pharma Waiver 29/05/2015 by Catherine Saez, Intellectual Property Watch 3 Comments Over 140 non-governmental organisations, most of them local from developing countries, have co-signed a letter to World Trade Organization members to ask they agree to a request by least-developed countries to extend a waiver on their obligation to enforce intellectual property rights on pharmaceutical products.
Panel: Compulsory Licensing Could Address High-Priced Medicines In Europe 28/05/2015 by Eimear Murphy for Intellectual Property Watch 3 Comments The high prices of medicine, which affects access to affordable medicine, was a theme of the annual World Health Assembly over the past week. In one side event, a panel discussed compulsory licensing as a vehicle to be used in combatting the high prices of medicine, not only in developing countries, but in Europe.
World Health Assembly Concludes With Actions On Range Of Issues 27/05/2015 by Catherine Saez, Intellectual Property Watch Leave a Comment The 68th World Health Assembly (WHA), which took place from 18-26 May, was characterised as one of the most successful annual assemblies ever by Margaret Chan, World Health Organization director general. From the standpoint of intellectual property, access and innovation, this may be debatable. Below is a guide to the main accomplishments highlighted by Intellectual Property Watch. These include: action plans to fight antibiotic resistance and to boost vaccinations, extension of the Global Strategy and Plan of Action on Public Health, Innovation and Intellectual Property (GSPA), incremental progress on alternative research and development for neglected diseases, status of the pandemic influenza preparedness framework, response to emergencies like Ebola, and WHO’s relationship with lobbyists and donors.
WHO Engagement With Non-State Actors: No Deal This Year, Work To Continue 26/05/2015 by Catherine Saez and William New, Intellectual Property Watch Leave a Comment The annual World Health Assembly closed today following a decision to postpone for one year completion of a new policy on the UN agency’s engagement with industry, foundations and other “non-state actors.”
WHA Committees Approve Plans On Antimicrobial Resistance, Vaccines, Innovation 25/05/2015 by Catherine Saez, Intellectual Property Watch 1 Comment Today, member states in committee at the World Health Assembly adopted the first global plan of action to address the issue of antimicrobial resistance, and a global plan of action on vaccines. In addition, a mechanism on public health, innovation and intellectual property was postponed until 2022, and a deadline for its evaluation moved to 2018.
WHA 68: Experts Discuss Delinking R&D Costs From Pricing To Make Medicines Affordable 25/05/2015 by William New, Intellectual Property Watch 1 Comment The problem of drug prices eating up national health budgets has been coming up at the annual World Health Assembly. Last week, a panel of experts discussed the merits of lowering those prices by delinking research and development costs from pricing.
WHO Advances R&D Financing Effort; Global R&D Observatory To Launch In January 24/05/2015 by Catherine Saez and William New, Intellectual Property Watch 2 Comments World Health Organization members in committee this week took note of a report by the Consultative Expert Working Group on Research and Development: Financing and Coordination (CEWG), which was set up to find ways to fund research on diseases afflicting poor populations which have little market incentive for the private sector. The report included a proposal for a voluntary pooled fund that would focus on the development of effective and affordable health technologies for such neglected diseases.
Review Of WHO Mechanism To Fight Substandard Medicines Postponed Until 2017 22/05/2015 by Catherine Saez, Intellectual Property Watch 1 Comment World Health Organization delegates today agreed in committee to postpone until 2017 the review of a mechanism that had been set up to help countries deal with substandard and fake medicines.